Trial intelligence / Profile preview

Safety of Solifenacin and Tamsulosin Co-administration in Men with LUTS and BOO

NCT00507455Phase 2Completed

Sponsor
Astellas Pharma
Start
Jun 2007
Primary completion
Aug 2008
Modality
Orthosteric Ligands
Countries
6
01

Overview

A Phase 2 trial of solifenacin in lower urinary tract symptoms (LUTS), bladder outlet obstruction (BOO), sponsored by Astellas Pharma. Started Jun 2007; status: completed.

02

Drugs

solifenacin
03

Conditions

lower urinary tract symptoms (LUTS)bladder outlet obstruction (BOO)

Beyond the preview

Go deeper on NCT00507455.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00507455.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call